Max Robotics — Global Service Robot Directory + US Certification

About

Pierre-Yves Bondiau is a pioneering radiation oncologist whose research centers on the integration of robotic stereotactic radioablation with neo-adjuvant chemotherapy for breast cancer treatment. His most influential work, a 2009 study on robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors, has garnered 30 citations and established a foundation for non-invasive, precisely targeted radiation delivery. Bondiau's contributions include demonstrating the feasibility and safety of combining advanced robotic radiosurgery with systemic therapy to enhance tumor response while minimizing damage to healthy tissue. He further explored this approach in a Phase 2 trial on robotic stereotactic boost in early breast cancer (2018) and documented a rare case of long-term survival in an atlas osteosarcoma treated with surgery, chemotherapy, and robotic stereotactic radiotherapy (2010). His work represents a significant advancement in stereotactic body radiation therapy (SBRT) applications, offering patients more effective, less toxic treatment options. Bondiau's research continues to influence clinical protocols for integrating robotic precision radiotherapy into multimodal cancer care.